The regulatory role of miRNAs on VDR in breast cancer

Transcription. 2017 Aug 8;8(4):232-241. doi: 10.1080/21541264.2017.1317695. Epub 2017 Jun 9.

Abstract

Triple negative breast cancer (TNBC) has been associated with the lack of three hormone receptors; estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). However, a host of other steroid hormone receptors such as vitamin D receptor (VDR) is present in TNBC, and the role of these hormone receptors in breast tumorigenesis is unclear. The levels of microRNAs (miRNAs) are also expressed differently than in normal mammary epithelial cells. miRNAs are regulatory RNAs involved in various cellular functions, mainly gene silencing. Here, we reviewed the literature surrounding miRNAs in breast cancer, and performed in silico analysis to determine whether there was a correlation between levels of VDR in relation to miRNAs important in breast cancer development and tumorigenesis. We identified three miRNAs of interest, specifically, miR-23, miR-124, and miR-125. Through this research we determined the possibility that these miRNAs play an important role in controlling VDR activity and by virtue the development of breast cancer.

Keywords: VDR; biomarker; breast cancer; miR-125; miRNAs; treatment resistance; tumor suppressor.

Publication types

  • Review

MeSH terms

  • Female
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Humans
  • MicroRNAs / genetics*
  • Receptors, Calcitriol / genetics*
  • Triple Negative Breast Neoplasms / genetics*

Substances

  • MIRN124 microRNA, human
  • MIRN125 microRNA, human
  • MIRN23a microRNA, human
  • MicroRNAs
  • Receptors, Calcitriol
  • VDR protein, human